Table 3.
Groups | Controls | Cytology | HPV |
---|---|---|---|
No. of eligible patients | 31,488 | 32,058 | 34,126 |
Assigned but not screened | NA | 6509 | 6934 |
Ca diagnosed in women with negative screening test results | NA | 22 | 8 |
Stage IA | NA | 2/22 (9.1%) | 0/8 (0%) |
Stage IB | NA | 4/22 (18.2%) | 2/8 (25.0%) |
Stage II+ | NA | 15/22 (68.2%) | 5/8 (62.5%) |
Stage unknown | NA | 1/22 (4.5%) | 1/8 (12.5%) |
Deaths among Ca diagnosed in women with negative screening test results | NA | 9/22 (40.9%) | 0/8 (0%) |
Ca detected among controls | 118 | ||
Ca deaths among controls | 64 |